SmartKem appoints Barbra C. Keck as CFO; grants 450,000 stock options

SmartKem, Inc.

Barbra C. Keck appointed CFO effective December 14, 2022; she will resign from Audit and Compensation Committees but remain on board.
Annual base salary of $300,000; eligible for annual bonus up to 40% based on KPIs.
Granted options to purchase 450,000 shares at $2.00 per share under 2021 Equity Incentive Plan.
Options vest: 150,000 shares after one year, remainder ratably monthly over two years.
Ms. Keck previously served on the board since Feb 2021 and was CFO of Deverra Therapeutics.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Barbra C. Keck

Chief Financial Officer

SMTK · SmartKem, Inc.

Effective: 2022-12-14
Filed: December 20, 2022, 6:59 PM ET

Effective December 14, 2022, SmartKem, Inc. (the “Company”) appointed Barbra C. Keck as the Company’s Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Barbra C. Keck was appointed as Chief Financial Officer at SmartKem, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Effective December 14, 2022, SmartKem, Inc. (the “Company”) appointed Barbra C. Keck as the Company’s Chief Financial Officer.

View on SEC.gov

SmartKem, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-22-018827

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.